An unusual case of phenotype switch between AML FAB subtypes

Phenotypic switch between any leukemia subtypes is of concern to a treating physician and more so, in acute myelocytic leukemia (AML) as the mechanisms for switch and subsequent chemotherapy regimen to be used remain unclear. AML-non-M3 from AML-M3 subtype needs special mention as this has been unhe...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Animesh, Singh, Amitabh, Gajendra, Smeeta, Gupta, Ritu, Sazawal, Susha, Seth, Rachna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352367/
https://www.ncbi.nlm.nih.gov/pubmed/25767711
http://dx.doi.org/10.1002/ccr3.169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352367/
https://www.ncbi.nlm.nih.gov/pubmed/25767711
http://dx.doi.org/10.1002/ccr3.169

Ejemplares similares